Mizzen C A, Cartel N J, Yu W H, Fraser P E, McLachlan D R
Centre for Research in Neurodegenerative Diseases, University of Toronto, Ontario, Canada.
J Biochem Biophys Methods. 1996 May 14;32(2):77-83. doi: 10.1016/0165-022x(95)00044-r.
Standard immunoblotting procedures were unable to detect metallothioneins-1 and 2 (MT-1, MT-2) and metallothionein-3 (MT-3)/growth inhibitory factor (GIF) in unfractionated brain homogenates. We have developed a novel process which involves the inclusion of 2 mM CaCl2 in electrophoretic transfer buffers and glutaraldehyde fixation following transfer to either nitrocellulose or polyvinylidene difluoride (PVDF) membranes. Using commercial MT antibodies and a specific MT-3 polyclonal antibody raised in our laboratory, we have been able to detect all three MTs on both membrane types with a detection limit of approx. 10 ng for MT-1 and MT-2. Nitrocellulose membrane pore size had no noticeable effect on detection sensitivity. These modifications enable more sensitive MT detection than previously described blotting methods. In addition, this technique eliminates the need for indirect monitoring approaches and simplifies quantification since sample fractionation or enrichment are not required.
标准免疫印迹程序无法在未分级的脑匀浆中检测到金属硫蛋白-1和2(MT-1、MT-2)以及金属硫蛋白-3(MT-3)/生长抑制因子(GIF)。我们开发了一种新方法,即在电泳转移缓冲液中加入2 mM氯化钙,并在转移至硝酸纤维素或聚偏二氟乙烯(PVDF)膜后进行戊二醛固定。使用市售的MT抗体和我们实验室制备的特异性MT-3多克隆抗体,我们能够在两种膜类型上检测到所有三种MT,MT-1和MT-2的检测限约为10 ng。硝酸纤维素膜孔径对检测灵敏度没有明显影响。这些改进使得MT检测比以前描述的印迹方法更灵敏。此外,该技术无需间接监测方法,并且由于不需要样品分级或富集,简化了定量过程。